FDA Output
FDA Output, June 2026
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in June 2026. Updated June 30.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Medtech Capital Matters
MedTech Capital Matters June 2026
Each month we survey selected private financings across medtech. Urology emerged as an unexpected standout this month.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Pathways’ Pick of the Week
Pathways' Pick of the Week: EU Council Urges Quick Action on MDR/IVDR Reforms
Health ministers push for changes and action on MDR/IVDR reforms. Excerpted from Pathways’ Picks June 17: EU Health Ministers Weigh Reforms, UK-US Liaisons, and TAVR Milestone.